References
- Allegra C, Antignani PL, Schachter I, Koverech A, Messano M, Virmani A. (2008). Propionyl-L-carnitine in Leriche-Fontaine stage II peripheral arterial obstructive disease. Ann Vasc Surg 22:552–558.
- Andreozzi GM, Leone A, Laudani R, Martin R, Deinit G, Cataldi V. (2008). Levo-propionyl-carnitine improves the effectiveness of supervised physical training on the absolute claudication distance in patients with intermittent claudication. Angiology 59:84–89.
- Andreozzi GM. (2009). Propionyl l-carnitine: intermittent claudication and peripheral arterial disease. Expert Opin Pharmacother 10:2697–2707.
- Angelini C, Lücke S, Cantarutti F. (1976). Carnitine deficiency of skeletal muscle: report of a treated case. Neurology 26:633–637.
- Bene J, Komlósi K, Havasi V, Talián G, Gasztonyi B, Horváth K, Mózsik G, Hunyady B, Melegh B, Figler M. (2006). Changes of plasma fasting carnitine ester profile in patients with ulcerative colitis. World J Gastroenterol 12:110–113.
- Brunner M, Assandri R, Kletter K, Tschurlovits M, Corrado ME, Villa R, Eichler HG, Müller M. (2003). Gastrointestinal transit and 5-ASA release from a new mesalazine extended-release formulation. Aliment Pharmacol Ther 17:395–402.
- Brunner M, Greinwald R, Kletter K, Kvaternik H, Corrado ME, Eichler HG, Müller M. (2003). Gastrointestinal transit and release of 5-aminosalicylic acid from 153Sm-labelled mesalazine pellets vs. tablets in male healthy volunteers. Aliment Pharmacol Ther 17:1163–1169.
- Christensen FN, Davis SS, Hardy JG, Taylor MJ, Whalley DR, Wilson CG. (1985). The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations. J Pharm Pharmacol 37:91–95.
- D’Argenio G, Calvani M, Casamassimi A, Petillo O, Margarucci S, Rienzo M, Peluso I, Calvani R, Ciccodicola A, Caporaso N, Peluso G. (2006). Experimental colitis: decreased Octn2 and Atb0+ expression in rat colonocytes induces carnitine depletion that is reversible by carnitine-loaded liposomes. FASEB J 20:2544–2546.
- Davis SS, Hardy JG, Newman SP, Wilding IR. (1992). Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur J Nucl Med 19:971–986.
- Digenis GA, Sandefer EP, Parr AF, Beihn R, McClain C, Scheinthal BM, Ghebre-Sellassie I, Iyer U, Nesbitt RU, Randinitis E. (1990). Gastrointestinal behavior of orally administered radiolabeled erythromycin pellets in man as determined by gamma scintigraphy. J Clin Pharmacol 30:621–631.
- Gasbarrini G, Mingrone G, Giancaterini A, De Gaetano A, Scarfone A, Capristo E, Calvani M, Caso V, Greco AV. (2003). Effects of propionyl-L-carnitine topical irrigation in distal ulcerative colitis: a preliminary report. Hepatogastroenterology 50:1385–1389.
- Kamm MA, Sandborn WJ, Gassull M, Schreiber S, Jackowski L, Butler T, Lyne A, Stephenson D, Palmen M, Joseph RE. (2007). Once-daily, high-concentration MMX mesalamine in active ulcerative colitis. Gastroenterology 132:66–75; quiz 432.
- Lichtenstein GR, Kamm MA, Sandborn WJ, Lyne A, Joseph RE. (2008). MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations. Aliment Pharmacol Ther 27:1094–1102.
- Longo A, Bruno G, Curti S, Mancinelli A, Miotto G. (1996). Determination of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine in human plasma by high-performance liquid chromatography after pre-column derivatization with 1-aminoanthracene. J Chromatogr B, Biomed Appl 686:129–139.
- Mikhailova T, Sishkova E, Poniewierka E, Zhidcov K, Bakulin I, Kupcinskas L, Leśniakowski K, Grinevich V, Małecka-Panas E, Ardizzone S, D’Arienzo A, Valpiani D, Koch M, Denapiene G, Vago G, Fociani P, Zerbi P, Ceracchi M, Camerini R, Gasbarrini G. (2011). A randomised, parallel-group, placebo-controlled, doubleblind, multicentre trial on the efficacy and safety of propionyl-L-carnitine therapy in patients with ulcerative colitis receiving stable oral treatment. Submitted to Aliment Pharmacol Ther.
- Pace S, Longo A, Toon S, Rolan P, Evans AM. (2000). Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption. Br J Clin Pharmacol 50:441–448.
- Sandborn WJ, Kamm MA, Lichtenstein GR, Lyne A, Butler T, Joseph RE. (2007). MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials. Aliment Pharmacol Ther 26:205–215.
- Wilding IR, Coupe AJ, Davis SS. (2001). The role of gamma-scintigraphy in oral drug delivery. Adv Drug Deliv Rev 46:103–124.
- Wiseman LR, Brogden RN. (1998). Propionyl-L-carnitine. Drugs Aging 12:243–8; discussion 249.